Circulating Tumor DNA Identifies EGFR Coamplification as a Mechanism of Resistance to Crizotinib in a Patient with Advanced MET-Amplified Lung Adenocarcinoma.

Autor:	Dagogo-Jack I; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., Fabrizio D; Foundation Medicine, Cambridge, Massachusetts., Lennerz J; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Schrock AB; Foundation Medicine, Cambridge, Massachusetts., Young L; Foundation Medicine, Cambridge, Massachusetts., Mino-Kenudson M; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Digumarthy SR; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts., Heist RS; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., Ali SM; Foundation Medicine, Cambridge, Massachusetts., Miller VA; Foundation Medicine, Cambridge, Massachusetts., Shaw AT; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: ashaw1@partners.org.
Jazyk:	angličtina
Zdroj:	Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2017 Oct; Vol. 12 (10), pp. e155-e157. Date of Electronic Publication: 2017 May 09.
DOI:	10.1016/j.jtho.2017.04.023
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu